Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Chan

Showing results (261-270 of 263) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 263 results.
Journal of Medicinal Chemistry|March 2, 2026
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12CNicholas F Endres, Steven Do, Rana Mroue, et al.
Histopathology|May 14, 2025
Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologistsMahra Nourbakshs, Liping Du, Andres M Acosta, et al.
Cancer Discovery|July 8, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly, Megan T Hoffman, Laleh Abbassi, et al.
Pageof 27

Showing results (261-270 of 263) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 263 results.
Journal of Medicinal Chemistry|March 2, 2026
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12CNicholas F Endres, Steven Do, Rana Mroue, et al.
Histopathology|May 14, 2025
Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologistsMahra Nourbakshs, Liping Du, Andres M Acosta, et al.
Cancer Discovery|July 8, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly, Megan T Hoffman, Laleh Abbassi, et al.
Pageof 27